| Nov 20 |
23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation
|
| Nov 13 |
23andMe to lay off more than 200 employees amid business struggles
|
| Nov 13 |
23andMe Holding Co (ME) Q2 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...
|
| Nov 13 |
Q2 2024 23andMe Holding Co. Earnings Call
|
| Nov 12 |
23andMe Holding Co. (ME) Q2 2025 Earnings Call Transcript
|
| Nov 12 |
23andMe is falling apart
|
| Nov 12 |
23andMe cuts 40% of its workforce
|
| Nov 12 |
Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs
|
| Nov 12 |
After its entire board resigned overnight, 23andMe will cut over 200 employees and its cancer research in an urgent bid to nurse the company back to health
|
| Nov 12 |
23andMe cuts 40% of its workforce and discontinues therapeutics division
|
